Suppr超能文献

成人局限性滑膜肉瘤:2004 年至 2013 年期间在维也纳大学肿瘤学系登记的 26 例患者的回顾性单中心分析。

Initially localized synovial sarcoma in adults: a retrospective single-center analysis of 26 patients registered at the Department of Oncology, University of Vienna between 2004 and 2013.

机构信息

Clinical Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

出版信息

Oncology. 2014;87(1):48-57. doi: 10.1159/000363185. Epub 2014 Jun 25.

Abstract

BACKGROUND

Synovial sarcoma is a rare subgroup of all soft-tissue sarcomas. The aim of this retrospective single-center analysis was to investigate the outcome of patients with initially localized disease.

PATIENTS AND METHODS

Twenty-six patients were enrolled in this retrospective single-center analysis. Baseline characteristics, treatment and outcome were evaluated.

RESULTS

In 13 patients (50%), the tumor was located in the lower extremity and in 4 patients (15%) in the upper extremity. Surgical resection was done in all but 2 patients (92%). Re-resection was done in 7 patients (27%). Fourteen patients (54%) received adjuvant chemotherapy. After a median follow-up of 23.3 months (range: 2.6-150.3), median disease-free survival was not reached at the time of analysis. Eight patients (31%) relapsed after initial therapy. Surgery was done in 2 patients, amputation in 1 patient, palliative chemotherapy was administered in 3 and radiation therapy in 2 patients. Median overall survival (OS) for all patients was not reached at the time of analysis. The estimated 5-year OS rate was 62%.

CONCLUSION

Patients with initially localized synovial sarcoma who were included in this retrospective single-center analysis have an estimated 5-year OS rate of 62%.

摘要

背景

滑膜肉瘤是所有软组织肉瘤中的一个罕见亚组。本回顾性单中心分析的目的是研究最初局限性疾病患者的预后。

患者和方法

本回顾性单中心分析共纳入 26 名患者。评估了基线特征、治疗和结局。

结果

13 名患者(50%)肿瘤位于下肢,4 名患者(15%)位于上肢。除 2 名患者(92%)外,所有患者均行手术切除。7 名患者(27%)行再次切除术。14 名患者(54%)接受辅助化疗。中位随访 23.3 个月(范围:2.6-150.3)后,分析时无疾病无进展生存的中位时间尚未达到。8 名患者(31%)在初始治疗后复发。2 名患者行手术,1 名患者行截肢,3 名患者行姑息化疗,2 名患者行放疗。分析时所有患者的中位总生存(OS)尚未达到。估计的 5 年 OS 率为 62%。

结论

本回顾性单中心分析纳入的最初局限性滑膜肉瘤患者估计 5 年 OS 率为 62%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验